LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation on behalf of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ: ICUI) investors concerning the Company and its officers’ possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
On May 8, 2020, ICU announced that it was “voluntarily recalling one single lot of Lactated Ringer’s Injection, USP, . . . due to the presence of particulate matter identified as iron oxide.”
On this news, ICU’s stock price fell $19.26 per share, or nearly 9%, to close at $198.10 per share on May 8, 2020, on unusually heavy trading volume.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased ICU securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to email@example.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.